Showing 1,181 - 1,200 results of 6,439 for search '"Heart"', query time: 0.11s Refine Results
  1. 1181

    Heart-Derived Stem Cells in Miniature Swine with Coronary Microembolization: Novel Ischemic Cardiomyopathy Model to Assess the Efficacy of Cell-Based Therapy by Gen Suzuki, Rebeccah F. Young, Merced M. Leiker, Takayuki Suzuki

    Published 2016-01-01
    “…Thus, global infusion of CDCs could become a new therapy to reverse LV dysfunction in patients with asymptomatic heart failure.…”
    Get full text
    Article
  2. 1182
  3. 1183
  4. 1184
  5. 1185

    Effect of galectin-3 and brain natriuretic peptide levels on echocardiographic parameters of left heart chamber following coronary artery bypass grafting by Yulia A. Styazhkina, Irina F. Grishina, Nina B. Poletaeva, Tatyana F. Peretolchina, Olga V. Nikolaenko

    Published 2024-12-01
    “…AIM: To assess the diagnostic value of left heart chamber remodeling, non–conventional markers NT-proBNP and galectin-3 in predicting the risk of prolonged recovery in patients with CAD following CABG. …”
    Get full text
    Article
  6. 1186

    The value of lung ultrasound score combined with echocardiography in assessing right heart function in patients undergoing maintenance hemodialysis and experiencing pulmonary hypertension by Ying Xia, Xin Liu

    Published 2025-01-01
    “…Divided into three groups based on PASP, and perform echocardiography and lung ultrasound examinations. Compare the right heart function parameters and LUS among the three groups. …”
    Get full text
    Article
  7. 1187
  8. 1188
  9. 1189
  10. 1190

    A Combination of Tachycardia-Mediated Heart Failure and Coronary Artery Vasospasm-Induced Silent Myocardial Infarction in a Patient with Severe Thyrotoxicosis by Serena Sert Kim Khoo, Chong Mow Chu, Yin Khet Fung

    Published 2018-01-01
    “…It may be mild features such as palpitations, tachycardia, and exertional dyspnea or may progress to life-threatening consequences such as atrial fibrillation, tachyarrhythmias, heart failure, myocardial infarction, and shock. …”
    Get full text
    Article
  11. 1191
  12. 1192

    Ultra‐short‐term versus short‐term measures of heart rate variability in specialist police units: A pilot reliability study by Colin D. Tomes, Elisa F. D. Canetti, Ben Schram, Robin Orr

    Published 2025-01-01
    “…As such, holistic stress measures may be valuable for quantifying multifactorial stress accumulation in SWAT personnel. Heart rate variability (HRV) is one field‐deployable measure that may be suitable in this context. …”
    Get full text
    Article
  13. 1193

    Enhancing Clinical Decision Making by Predicting Readmission Risk in Patients With Heart Failure Using Machine Learning: Predictive Model Development Study by Xiangkui Jiang, Bingquan Wang

    Published 2024-12-01
    “… Abstract BackgroundPatients with heart failure frequently face the possibility of rehospitalization following an initial hospital stay, placing a significant burden on both patients and health care systems. …”
    Get full text
    Article
  14. 1194

    Heart Rate Variability: A Psychophysiological Factor Related to Both Regular Physical Activity and Eudaimonic Well‐Being Among Young Adults by Yoshino Murakami, Daisuke Goto, Hayato Tsukamoto, Kazuho Yamaura, Takeshi Hashimoto

    Published 2025-01-01
    “…PA, mindfulness‐related psychophysiological factors (including serotonin [5‐HT], oxytocin [OXT]), and dopamine [DA] levels), and heart rate variability (HRV) have been shown to be associated with mental disorders or emotion regulation capacity. …”
    Get full text
    Article
  15. 1195

    Effects of Fasudil on Patients with Pulmonary Hypertension Associated with Left Ventricular Heart Failure with Preserved Ejection Fraction: A Prospective Intervention Study by Xiang Zhang, Xueming Zhang, Saihua Wang, Jun Luo, Zhihong Zhao, Changzhu Zheng, Jieyan Shen

    Published 2018-01-01
    “…Pulmonary hypertension due to left ventricular heart failure with preserved ejection fraction (PH-HFpEF) is an increasingly medical problem. …”
    Get full text
    Article
  16. 1196

    Identifying research priorities in cardiac surgery: a report from the James Lind Alliance Priority Setting Partnership in adult heart surgery by Tracy Kumar, Florence Y Lai, Riccardo G Abbasciano, Bethany Tabberer, Gavin J Murphy

    Published 2020-09-01
    “…Objective To identify research priorities that address the needs of people affected by cardiac surgery and those who support and care for them.Design James Lind Alliance (JLA) process—two surveys and a consensus workshop guided by an independent JLA adviser.Setting The UK with international participation.Participants Three stakeholder groups—heart surgery patients, carers and healthcare professionals involved in care delivery.Methods The initial survey was set to collect potential research questions in cardiac surgery as identified by stakeholders. …”
    Get full text
    Article
  17. 1197

    Cost of primary care approaches for hypertension management and risk-based cardiovascular disease prevention in Bangladesh: a HEARTS costing tool application by Andrew E Moran, Sohel Reza Choudhury, Deliana Kostova, Muhammad Jami Husain, Mohammad Sabbir Haider, Mahfuzur Rahman Bhuiyan, Renesa Tarannum, Shamim Jubayer

    Published 2022-06-01
    “…Objective To estimate the costs of scaling up the HEARTS pilot project for hypertension management and risk-based cardiovascular disease (CVD) prevention at the full population level in the four subdistricts (upazilas) in Bangladesh.Settings Two intervention scenarios in subdistrict health complexes: hypertension management only, and risk-based integrated hypertension, diabetes, and cholesterol management.Design Data obtained during July–August 2020 from subdistrict health complexes on the cost of medications, diagnostic materials, staff salaries and other programme components.Methods Programme costs were assessed using the HEARTS costing tool, an Excel-based instrument to collect, track and evaluate the incremental annual costs of implementing the HEARTS programme from the health system perspective.Primary and secondary outcome measures Programme cost, provider time.Results The total annual cost for the hypertension control programme was estimated at US$3.2 million, equivalent to US$2.8 per capita or US$8.9 per eligible patient. …”
    Get full text
    Article
  18. 1198
  19. 1199

    Predicted quality benefits of achievable performance benchmarks of chronic heart failure care in China: results from a nationwide observational study by Xi Li, Chao Wang, Jingkun Li, Yupeng Wang, Xiaoqiang Bao, Meina Liu, Qiuju Zhang, Chang Yin, Xudong Ma

    Published 2020-09-01
    “…Objectives This study aimed to set a data-driven achievable performance benchmark, explore the process–outcome association and speculate about the net gain in quality improvement with benchmarking.Design Observational study.Setting Patient survey conducted at 466 secondary and tertiary hospitals across 31 provinces, autonomous regions and municipalities in China.Participants 183 334 patients diagnosed with chronic heart failure (CHF) who were treated at 466 Chinese hospitals from January 2011 through May 2017.Primary independent variables Hospital process composite performance (HPCP).Secondary independent variables Patient-level and hospital-level characteristics.Primary outcome measure Patients getting better or recovered after treatment, in-hospital mortality, length of hospital stay (LOS) and medical cost.Methods HPCP was calculated using denominator-based weights. …”
    Get full text
    Article
  20. 1200